International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: 10.5281/zenodo.13734304
Case Report
Nutrition and Polytrauma: The Role of Peptide-Based High Calorie, High Protein in Early And Effective Wound Healing
Published
Sept. 9, 2024
Abstract

Inadequate initial trauma management might result in a high fatality rate. Moreover, unexpected injury results in changes to metabolism, inflammation, and haemodynamics. Enteral nutrition (EN) is strongly advised as a feeding access method rather than parenteral nutrition (PN) according to the American Society for Parenteral and Enteral Nutrition (ASPEN) standards. Enteral tube feeding is now the most widely used technique of providing nutritional support for critically ill individuals due to significant advancements in enteral formulations over the past several years. Formulas based on peptides comprise proteins that have undergone hydrolysis to yield peptides of different lengths. Here, we describe a patient's experience receiving postoperative intensive care unit (ICU) care while receiving dietary therapy. Enteral nutrition (EN) was not started for more than two weeks, despite the patient's lack of malnutrition at ICU admission. The present case study underscores the significance of nutrition interventions for critically ill trauma patients who are at increased risk of malnourishment. It demonstrates the efficaciousness of peptide-based high-protein, high-calorie, and appropriate nutrition therapy in meeting the patients' nutritional requirements and promoting prompt wound healing.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1112 Views
126 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved